AG019FVC

73384-59-5 | Ceftriaxone

Chemical structure of Ceftriaxone, CAS 73384-59-5
AG019FVC
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 73384-59-5
Catalog Number AG019FVC(AGN-PC-0U31U9)
Chemical Name Ceftriaxone
IUPAC Name (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
InChI InChI=1S/C18H18N8O7S3/c1-25-18(22-12(28)13(29)23-25)36-4-6-3-34-15-9(14(30)26(15)10(6)16(31)32)21-11(27)8(24-33-2)7-5-35-17(19)20-7/h5,9,15H,3-4H2,1-2H3,(H2,19,20)(H,21,27)(H,23,29)(H,31,32)/b24-8-/t9-,15-/m1/s1
InChI Key VAAUVRVFOQPIGI-SPQHTLEESA-N
MDL Number MFCD00865013
Molecular Formula C18H18N8O7S3
Molecular Weight 554.5799
SMILES NC=1SC=C(N1)/C(/C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)CSC=1N(NC(C(N1)=O)=O)C)=N/OC
UNII 75J73V1629
Synonyms
Anhydrous Ceftriaxone Sodium, Benaxona, Cefatriaxone, Cefaxona, Ceftrex, Ceftriaxon, Ceftriaxon Curamed, Ceftriaxon Hexal, Ceftriaxona Andreu, Ceftriaxona LDP Torlan, Ceftriaxone, Ceftriaxone Irex, Ceftriaxone Sodium, Ceftriaxone Sodium, Anhydrous, Ceftriaxone, Disodium Salt, Ceftriaxone, Disodium Salt, Hemiheptahydrate, Lendacin, Longacef, Longaceph, Ro 13 9904, Ro 13-9904, Ro 139904, Ro-13-9904, Ro13 9904, Ro13-9904, Ro139904, Rocefalin, Rocefin, Rocephin, Rocephine, Tacex, Terbac, ceftriaxone, Biotrakson, Rocephin, Ceftriaxona, Ceftriaxonum, Rocefin, Ceftriazone, Rocephine, Ceftriaxonum [INN-Latin], Ceftriaxona [INN-Spanish], 73384-59-5, Cefatriaxone, Ro 139904, CEFTRIAXONE SODIUM, DRG-0071, Rocephalin, Ro 13-9904, CHEBI:29007, C18H18N8O7S3, UNII-75J73V1629, EINECS 277-405-6, CHEMBL161, CTRX, Ceftriaxon, Longacef, 75J73V1629, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio)methyl)-, (6R-(6alpha,7beta(Z)))-, W-104454, Ceftriaxone and Dextrose in Duplex Container, Ro 13-9904/001, Ceftriaxone sodium hydrate, 74578-69-1, Rophex, Ceftriaxone [USAN:JAN], Ceftriaxone, Disodium Salt, X 13-9904, Ceftriaxone (TN), (6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, Ceftriaxone (INN), Ceftriaxone intravenous, Cephtriaxone, Ro-13-9904, VAAUVRVFOQPIGI-SPQHTLEESA-N, Ceftriaxone [USAN:INN:JAN], Ceftriaxone, Disodium Salt, Hemiheptahydrate, (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, Cefatriaxone hydrate, Ceftriaxone free acid, AC1NUIFE, SCHEMBL23354, (6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as-triazin-3-yl)thio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-(O-methyloxime), sesquaterhydrate, DTXSID0022773, HY-B0712, ZINC8584434, BDBM50049707, BDBM50103601, AKOS015960618, AC-1592, CS-2948, DB01212, (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-{[(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid, AN-14520, AN-14762, AN-37256, BC203714, K250, LS-150031, C06683, D07659, Cefatriaxone, Antibiotic for Culture Media Use Only, (6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-7-[2-(2-Amino-4-thiazolyl)glyoxylamido]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as-triazin-3-yl)thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7^2-(Z)-(O-, (6R,7R)-7-{2-(2-Amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-3-(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-[1,2,4]triazin-3-ylsulfanylmethyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-7-{2-(2-Amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-3-(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-[1,2,4]triazin-3-ylsulfanylmethyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R,)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-ylthio)methyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R,Z)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-ylthio)methyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R,Z)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-ylthio)methyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio)methyl)-, (6R,7R)-, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-, (6R,7R)-, 7-[2-(2-Amino-thiazol-4-yl)-2-methoxyimino-acetylamino]-3-(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-[1,2,4]triazin-3-ylsulfanylmethyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid (Ceftriaxone), 7-[2-(2-Amino-thiazol-4-yl)-2-methoxyimino-acetylamino]-3-(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-[1,2,4]triazin-3-ylsulfanylmethyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid(Ceftriaxone), 78384-59-5, Longaceph, Lendacin, Tartriakson, Benaxona, Cefaxona, Rocefalin, Ceftrex, Terbac, Tacex, Ceftriaxon Hexal, Ceftriaxone Irex, Ceftriaxon Curamed, Ceftriaxona Andreu, Rocephin (TN), Ceftriaxone disodium, Ceftriaxona LDP Torlan, Ceftriaxone [INN:BAN], Ceftriaxone EP Impurity A, Ceftriaxone Sodium [USP], D07ACT, Anhydrous Ceftriaxone Sodium, Ceftriaxone Sodium, Anhydrous, UNII-023Z5BR09K, UNII-R598PB148Q, Ceftriaxone in plastic container, Ro13-9904, C18H18N8O7S3.2Na, EINECS 277-930-0, Ceftriaxone sodium [USAN:USP:JAN], Ro139904, C18-H18-N8-O7-S3, CID5479530, CS-O-13165, Ro13 9904, C18-H18-N8-O7-S3.2Na, Ro 13 9904, C18H18N8O7S3.7/2H2O.2Na, Ceftriaxone disodium salt hemiheptahydrate, ROCEPHIN W/ DEXTROSE IN PLASTIC CONTAINER, C18-H18-N8-O7-S3.7/2H2-O.2Na, D002443, -7-[[ -2- -2-methoxyiminoacetyl]amino]-3-[ sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid, 104376-79-6, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-, disodium salt, [6R-[6alpha,7beta(Z)]]-, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-, (6R,7R)-, 9F2,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited